AxoSim is looking for an experienced Research Scientist (with Neuroscience focused drug discovery background) to join our innovative team. Learn more and apply: indeed.com/cmp/Axosim-Inc…

AxoSim is expanding its operations team. We are hiring for an experienced Director of Sales (10+ years exp.) to lead our growing preclinical CRO testing services and launch of new platforms and products currently in development. Learn more and apply: indeed.com/cmp/Axosim-Inc…

We are hiring for several positions on our team. Check out our jobs page: indeed.com/cmp/Axosim-Inc… and see if you would be a great fit. #hiring #biotechnology #researschscientists #sales #pharmaceuticalsales

And Jazz Fest canceled for the third time... nola.com/news/article_8…

We are proud of AxoSim team member Megan Terral who will be serving as an ambassador for the United MSD Foundation. The mission of Cure MSD is to cure Multiple Sulfatase Deficiency, a rare and fatal genetic condition that affects children. #TogetherWeCan #cureMSD #UMSDFAmbassador

Our team back in the lab post Hurricane Ida. We are excited to get back to our projects empowering advancements in human neuroscience. #neuroscience #drugdiscovery #biotechnology #teamculture

The acquisition of NOLA company Levelset by Procore Technologies is the largest exit in LA history, and a resounding win for the entrepreneurial ecosystem of Greater New Orleans.🔨💰🎉CONGRATS ·mETH Prσtσcol·, and THANK YOU The Idea Village | Startup | Nola & Gulf Coast, N.O. Startup Fund, et al.🙌bwnews.pr/2XMAl5i

Where do #organoids and #MPS fit in preclinical R&D? What drives adoption? Learn answers to these questions and more as I serve on a panel for Charles River Labs Human Translational Neuroscience discussion at Society for Neuroscience (SfN) Annual Meeting Nov 9 and 10: lnkd.in/gh5SVQnV #SfN2021

It's great to stop and remember why we all got into #Science! Feels like an uphill battle but the impact keeps us going. #neuroscience #translation #research

Please join the AxoSim webinar to learn about our 3D peripheral neurotox model and get a sneak peek at NerveSim 2.0

Many cancer patients face peripheral neuropathy from treatment. This is unacceptable. We need to understand why drugs are toxic and how to stop it much earlier. Join December 7th to learn how the AxoSim #NerveSim platform is helping solve this. shorturl.at/yCLQ7

We are pleased to announce we will be exhibiting at the 61st Annual Society of Toxicology Annual Meeting and ToxExpo in March. Our first in person conference since the pandemic. We are excited to meet you! #savethedate #2022SOT #drugdevelopment #biotechnology

Happy tissue #twosday! Head on over to the AxoSim Blog to check out Research Scientist Kevin Simpson’s, PhD, paper review on tissue clearing for 3D spheroid cell culture. #3dcellculturehttps://axosim.com/clearer-answers-ahead-optical-clearing-of-3d-spheroid-cell-cultures/

The acceptance of #organchip and #MPS data by the U.S. FDA is a huge milestone for the industry. Can't wait for more examples from technologies like Wyss Institute Emulate, Inc. AxoSim and many more

Read our Q&A with authors Michael J. Moore, PhD, and Wesley Anderson, PhD, highlighting their recent publication utilizing our NerveSim® platform to research opioid treatment alternatives. #blogpost #opioidepidemic #axosim lnkd.in/d9tYbkPa

This is why we do what we do! #Science